Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
354
Total Claims
$182K
Drug Cost
42
Beneficiaries
$4,340
Cost/Patient
Risk Score Breakdown 27/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+548%
Opioid rate vs peers
40.7% vs 6.3% avg
-68%
Cost per patient vs peers
$4,340 vs $14K avg
+86%
Brand preference vs peers
27.1% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 548% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
40.7%
Opioid Rate
144
Opioid Claims
$48K
Opioid Cost
39.6%
Long-Acting Rate
This provider's opioid prescribing rate of 40.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 96 claims · $174K
Generic: 258 claims · $8,661
Patient Profile
49
Avg Age
—
Female
5.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data